Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Xarelto Lawsuits Over Bleeding Problems Not Expected to Slow Sales, According to Bayer May 1, 2015 Austin Kirk Add Your Comments While a growing number of Xarelto lawsuits continue to be filed on behalf of individuals who have suffered severe and often fatal bleeding problems, Bayer reports that it anticipates sales for the controversial anticoagulant will continue to grow, with expected growth of 30% this year. According to Bayer’s first quarter financial report (PDF), there are now more than 500 complaints pending throughout the U.S. involving allegations that the drug maker failed to adequately warn about the potential risk of uncontrollable bleeding with Xarelto. In addition, at least five Xarelto class action lawsuits have been filed in Canada. Despite the mounting litigation, Bayer reports that Xarelto sales have exceeded half a billion dollars in the first quarter alone, setting it on an easy path to blockbuster status again this year, and dwarfing sales of competitors that are part of a new generation of novel oral anticoagulants, such as Pradaxa and Eliquis. Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Bayer also reported that estimated sales growth for Xarelto is should be higher than expected in 2015, increasing from a previous prediction of 20% growth to 30%. Internal Bleeding Problems on Xarelto Xarelto (rivaroxoaban) was introduced in 2011 as a superior replacement for Coumadin (warfarin), which has been the “go-to” medication for prevention of blood clots and strokes among patients with atrial fibrillation for decades. It was the second member of of this new generation introduced, and quickly grew to become the most widely used. While all blood thinners carry a risk of bleeding injury, Xarelto has been linked to a surprising number of bleeding problems as more and more patients are switched to the novel anticoagulant. Unlike warfarin, for which the blood thinning effects of the medication can be quickly reversed in the case of an emergency, there is no approved antidote for Xarelto, which has left many doctors helpless to stop hemorrhages or other bleeding experienced by users. While Bayer is currently working on obtaining an effective reversal agent, lawsuits have alleged that the drug never should have been introduced without an antidote or stronger warnings for doctors. Sales of Xarelto have been fueled by claims that it is easier to use than warfarin, which requires frequent blood monitoring. While the drug makers have promoted a one-size fits all approach, recent studies have raised questions about whether many of the bleeding problems may actually have been avoided if Bayer had recommended blood monitoring with Xarelto to help doctors identify patients at the greatest risk bleeds. Xarelto Bleeding Lawsuits In December 2014, amid the growing number of injury and wrongful death lawsuits over Xarelto filed throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established consolidated pretrial proceedings for the cases. The Xarelto litigation is currently centralized before U.S. District Judge Eldon Fallon in the Eastern District of Louisiana. Given the nearly identical allegations raised in the cases, the lawsuits have been consolidated to reduce duplicative discovery into common issues, avoid conflicting pretrial rulings from different judges and to serve the convenience of the parties, witnesses and the courts. One of the most recently filed lawsuits involves a complaint (PDF) brought this week by Frank Peck, which indicates that his wife, Ann, died after suffering uncontrollable internal bleeding and a hemorrhagic stroke. Ann Peck was prescribed Xarelto in late March 2013, and was dead by May 4, 2013. “Defendants routinely marketed Xarelto as a ‘one size fits all’ drug,” the lawsuit states.”In their fervent marketing of Xarelto, Defendants’ misinformed patients and their healthcare providers as to the necessity to routinely monitor any patient requiring a blood thinning agent.” Peck is pursuing claims against the drug makers for failure to warn, designing a defective drug, negligence, negligent design, negligent misrepresentation, breach of warranty, fraud, and violating consumer protection laws, seeking both compensatory and punitive damages. It is ultimately expected that several thousand complaints will be centralized before Judge Fallon, as Xarelto bleeding lawyers continue to review and file lawsuits. As part of the coordinated pretrial proceedings before Judge Fallon, it is expected that a small group of cases will be scheduled for early trial dates in the MDL. Known as “bellwether” cases, these trials will be designed to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the U.S. litigation. While the outcome of any early trial dates will not be binding in other cases, they may help the drug makers reach Xarelto settlements to avoid the need for hundreds of individual trials throughout the U.S. Tags: Bayer, Bleeding, Blood Thinner, Johnson & Johnson, Stroke, Warfarin, Xarelto More Xarelto Lawsuit Stories Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024 Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022 Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: yesterday) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 3 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 4 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: yesterday) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 3 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 4 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)